Sindhu R Johnson

Jul 11, 2024 | lupus.bmj.com | Ambika Gupta |Sindhu R Johnson |Michelle Barraclough |Jiandong Su

DiscussionThe aim of our study was to determine if self-reported outcomes, including the PDQ-20 and HRQoL, disease activity scores (SLEDAI-2K) and ACR-NB cluster into distinct groups in patients with SLE, and if these clusters change at 1-year follow-up. We found three distinct clusters of patients with SLE in association with PROs and cognition. Symptom burden was lowest in the mild cluster patients and highest in the severe cluster.

Jul 1, 2024 | jrheum.org | Sanjana Tarannum |Jessica Widdifield |C. Fangyun Wu |Sindhu R Johnson

Key Indexing Terms:disease-modifying antirheumatic drugspain medicationspsoriatic arthritisrheumatoid arthritissex differencesEarly initiation of disease-modifying antirheumatic drugs (DMARDs) is the cornerstone of therapy in both rheumatoid arthritis (RA) and psoriatic arthritis (PsA), leading to improved disease outcomes.1,2 Various aspects of these inflammatory forms of arthritis are associated with the sex of the patient.

May 9, 2024 | jrheum.org | Sanjana Tarannum |Jessica Widdifield |C. Fangyun Wu |Sindhu R Johnson

Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study Sanjana Tarannum, Jessica Widdifield, C. Fangyun Wu, Sindhu R. Johnson, Paula Rochon, Lihi Eder The Journal of Rheumatology May 2024, jrheum.2023-1148; DOI: 10.3899/jrheum.2023-1148